KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Return on Sales (2016 - 2025)

Eli Lilly's Return on Sales history spans 16 years, with the latest figure at 0.34% for Q4 2025.

  • For Q4 2025, Return on Sales rose 2.0% year-over-year to 0.34%; the TTM value through Dec 2025 reached 0.32%, up 8.0%, while the annual FY2025 figure was 0.32%, 8.0% up from the prior year.
  • Return on Sales reached 0.34% in Q4 2025 per LLY's latest filing, up from 0.32% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.36% in Q2 2025 to a low of 0.01% in Q3 2023.
  • Average Return on Sales over 5 years is 0.22%, with a median of 0.22% recorded in 2021.
  • Peak YoY movement for Return on Sales: dropped -22bps in 2023, then increased 23bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 0.22% in 2021, then grew by 23bps to 0.27% in 2022, then decreased by -12bps to 0.23% in 2023, then skyrocketed by 39bps to 0.33% in 2024, then increased by 6bps to 0.34% in 2025.
  • Per Business Quant, the three most recent readings for LLY's Return on Sales are 0.34% (Q4 2025), 0.32% (Q3 2025), and 0.36% (Q2 2025).